Adaptimmune Therapeutics shares owned by Captrust Financial Advisors
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Captrust Financial Advisors
from 13F filings
Historical chart of Captrust Financial Advisors investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Captrust Financial Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Captrust Financial Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $14k | 17k | 0.79 |
| 2023-09-30 | $17k | 22k | 0.78 |
| 2023-06-30 | $20k | 22k | 0.93 |
| 2023-03-31 | $24k | 22k | 1.09 |
| 2022-09-30 | $21k | 20k | 1.07 |
| 2022-06-30 | $8.0k | 4.6k | 1.73 |
| 2022-03-31 | $10k | 4.6k | 2.16 |
| 2021-12-31 | $4.0k | 940 | 4.26 |
| 2021-09-30 | $5.0k | 940 | 5.32 |
| 2021-06-30 | $4.0k | 940 | 4.26 |
| 2021-03-31 | $5.0k | 940 | 5.32 |
More positions owned by Captrust Financial Advisors
View all positions for Captrust Financial Advisors